Table IV.
Response rate | CR | PR | SD | PD | NE | RR | DCR |
---|---|---|---|---|---|---|---|
BBP− (n=27), n | 0 | 0 | 7 | 8 | 12 | 0 | 7 |
% | 0 | 0 | 25.9 | 29.6 | 44.4 | 0 | 25.9 |
BBP+ (n=15), n | 1 | 0 | 9 | 2 | 3 | 1 | 10 |
% | 6.7 | 0 | 60 | 13.3 | 20 | 6.7 | 66.7 |
CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease; NE, not examined; RR, response rate; DCR, disease control rate; BBP, bevacizumab beyond progression.